The iGem-team after their victory in Paris
The iGem-team after their victory in Paris - Student team iGEM TU/e developed a therapy for autoimmune diseases. TU/e's iGEM team has finished first at the Giant Jamboree in Paris, the international competition for innovations in synthetic biology. The students developed a cell therapy to treat autoimmune diseases such as ANCA-associated vasculitis, a chronic inflammation in blood vessels. Worldwide, 400 million people suffer from this type of diseases, which can be fatal. The Eindhoven team managed to beat the other two contestants from Hong Kong and France in the final of the undergrad category. It is the first time the student team has won the international competition. iGEM is an international student competition in which participants try to solve a variety of problems using techniques from synthetic biology.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
